Anti-spike protein assays to determine SARS-CoV-2 antibody levels: a head-to-head comparison of five quantitative assays
T Perkmann, N Perkmann-Nagele, T Koller… - Microbiology …, 2021 - Am Soc Microbiol
Reliable quantification of the antibody response to severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) is highly relevant, eg, for identifying possible vaccine failure …
coronavirus 2 (SARS-CoV-2) is highly relevant, eg, for identifying possible vaccine failure …
Viral infection neutralization tests: A focus on severe acute respiratory syndrome‐coronavirus‐2 with implications for convalescent plasma therapy
Viral neutralization tests (VNTs) have long been considered old‐fashioned tricks in the
armamentarium of fundamental virology, with laboratory implementation for a limited array of …
armamentarium of fundamental virology, with laboratory implementation for a limited array of …
Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection
J Van Elslande, M Oyaert, S Ailliet, M Van Ranst… - Journal of Clinical …, 2021 - Elsevier
Abstract Background Most SARS-CoV-2 infected patients develop IgG antibodies within 2–3
weeks after symptom onset. Antibody levels have been shown to gradually decrease in the …
weeks after symptom onset. Antibody levels have been shown to gradually decrease in the …
[HTML][HTML] Prevalence of neutralising antibodies against SARS-CoV-2 in acute infection and convalescence: A systematic review and meta-analysis
Background Individuals infected with SARS-CoV-2 develop neutralising antibodies. We
investigated the proportion of individuals with SARS-CoV-2 neutralising antibodies after …
investigated the proportion of individuals with SARS-CoV-2 neutralising antibodies after …
Humoral immune response to COVID‐19 vaccination in diabetes is age‐dependent but independent of type of diabetes and glycaemic control: the prospective …
C Sourij, NJ Tripolt, F Aziz, F Aberer… - Diabetes, Obesity …, 2022 - Wiley Online Library
Aims To investigate the seroconversion following first and second COVID‐19 vaccination in
people with type 1 and type 2 diabetes in relation to glycaemic control prior to vaccination …
people with type 1 and type 2 diabetes in relation to glycaemic control prior to vaccination …
Evaluation of high-throughput SARS-CoV-2 serological assays in a longitudinal cohort of patients with mild COVID-19: clinical sensitivity, specificity, and association …
A Bal, B Pozzetto, MA Trabaud, V Escuret… - Clinical …, 2021 - academic.oup.com
Background The association between SARS-CoV-2 commercial serological assays and
virus neutralization test (VNT) has been poorly explored in mild patients with COVID-19 …
virus neutralization test (VNT) has been poorly explored in mild patients with COVID-19 …
[HTML][HTML] Antibody isotype diversity against SARS-CoV-2 is associated with differential serum neutralization capacities
Understanding antibody responses to SARS-CoV-2 is indispensable for the development of
containment measures to overcome the current COVID-19 pandemic. Recent studies …
containment measures to overcome the current COVID-19 pandemic. Recent studies …
[HTML][HTML] Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies
Rapid and accurate measurement of the severe acute respiratory syndrome coronavirus 2
(SARS-CoV2)-specific neutralizing antibodies (nAbs) is paramount for monitoring immunity …
(SARS-CoV2)-specific neutralizing antibodies (nAbs) is paramount for monitoring immunity …
[HTML][HTML] Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and …
A Valdivia, I Torres, V Latorre… - European Journal of …, 2021 - Springer
Whether antibody levels measured by commercially available enzyme or chemiluminescent
immunoassays targeting the SARS-CoV-2 spike (S) protein can act as a proxy for serum …
immunoassays targeting the SARS-CoV-2 spike (S) protein can act as a proxy for serum …
Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: a method comparison …
T Mueller - Clinica Chimica Acta, 2021 - Elsevier
Background We compared two serological assays from Roche Diagnostics in individuals
with and without COVID-19 vaccination, namely the Elecsys Anti-SARS-CoV-2 assay …
with and without COVID-19 vaccination, namely the Elecsys Anti-SARS-CoV-2 assay …